CJC-1295 [with DAC]

CJC-1295 (With DAC) — Research Peptide

CJC-1295 with Drug Affinity Complex (DAC) is a synthetic peptide supplied for laboratory research purposes and represents a modified analogue of growth hormone–releasing hormone (GHRH). Within scientific literature, this compound has been referenced in studies examining receptor interactions and associated cellular signalling mechanisms under controlled experimental conditions.

The addition of DAC alters experimental handling characteristics compared with non-DAC variants by extending peptide activity in laboratory models. Provided as a lyophilised material, CJC-1295 with DAC is utilised within laboratory environments where precise preparation and controlled handling are required for research workflows.

Research Areas of Interest

Scientific literature referencing CJC-1295 with DAC includes investigation into areas such as:

• Experimental examination of receptor-associated cellular signalling processes within laboratory models
• Investigation of peptide interactions examined in endocrine-related research environments
• Evaluation of cellular response pathways studied under controlled experimental conditions
• Comparative research examining differences between DAC-modified and non-modified peptide variants within laboratory systems

These areas reflect ongoing scientific exploration and position CJC-1295 with DAC as a subject of continued laboratory research interest.

Technical Information

Product Name: CJC-1295 (With DAC)
Chemical Name: CJC-1295 with Drug Affinity Complex
Synonyms: DAC-GRF(1-29); Modified GRF(1-29) with DAC
Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: ~3368 g/mol
Amino Acid Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu
CAS Number: 863288-34-0
Classification: Synthetic growth hormone–releasing hormone analogue research peptide with DAC modification
Form: Lyophilised powder

Storage Guidelines

Lyophilised material remains stable at room temperature for short periods during laboratory handling.

For extended storage, material should be maintained at −20 °C or below. Following reconstitution, solutions should be stored refrigerated and handled according to standard laboratory protocols.

Solubility

CJC-1295 with DAC is typically soluble in sterile laboratory water, acetic acid, or suitable aqueous buffers depending on laboratory preparation requirements.

References

Teichman, S. L., et al. (2006). Studies examining long-acting GHRH analogue activity within controlled experimental models. Journal of Clinical Endocrinology & Metabolism, 91(3), 799–805.

Teichman, S. L., et al. (2004). Investigation of long-acting GHRH analogue characteristics within laboratory research contexts. Journal of Clinical Endocrinology & Metabolism, 89(11), 5286–5292.

Research Use Notice

This product is supplied strictly for laboratory research purposes only. It is not intended for human or veterinary consumption, therapeutic application, or diagnostic use. Products supplied are not medicines, food products, or cosmetic ingredients.